INS and Hypertension: Recently, insulin resistance, characterized by a decreased cellular response to insulin, was shown to have a significant impact on various adverse clinical outcomes, including hypertension, diabetes mellitus, nonalcoholic fatty liver disease, cardiovascular diseases, and even kidney diseases [15].